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A Genomewide Scan for Type 1–Diabetes Susceptibility in Scandinavian
Families: Identification of New Loci with Evidence of Interactions
European Consortium for IDDM Genome Studies1
Type 1 diabetes mellitus (TIDM) has a multifactorial etiology, with major genetic-susceptibility determinants located
in the HLA and insulin-gene (INS) regions. Linkage data implicating other disease-susceptibility loci are conflicting.
This is likely due to (1) the limited power for detection of contributions of additional susceptibility loci, given the
limited number of informative families available for study, (2) factors such as genetic heterogeneitybetweenpopulations,
and (3) potential gene-gene and gene-environment interactions. To circumvent some of these problems, we have
conducted a genomewide linkage analysis for T1DM-susceptibility loci in 408 multiplex families from Scandinavia,
a population expected to be homogeneous for genetic and environmental factors. In addition to verifying the HLA
and INS susceptibility loci, the study provides confirmation of IDDM15 on chromosome 6q21. Suggestive evidence
of additional susceptibility loci was found on chromosomes 2p, 5q, and 16p. For some loci, the support for linkage
increased substantially when families were stratified on the basis of HLA or INS genotypes, with statistically significant
heterogeneity between the stratified subgroups. Our data support both the existence of non-HLA genes of significance
for T1DM and interaction between HLA and non-HLA loci in the determination of the T1DM phenotype.
Introduction
Type 1 diabetes mellitus (T1DM [MIM 222100]) de-
velops in susceptible individuals because of a gradual
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autoimmune destruction of the insulin-producing b-cells
of the endocrine pancreas, with a consequent depen-
dence on daily insulin injections for survival. Increased
concordance for T1DM in MZ twins (30%–50%), com-
pared to that in DZ twins (4.8%–27%) and in siblings
(4.4%–12.5%), suggests that susceptibility is deter-
mined partly by genetic factors (Degnbøl and Green
1978; Tillil and Ko¨bberling 1987; Olmos et al. 1988;
Kaprio et al. 1992; Kumar et al. 1993; Lorenzen et al.
1994; Kyvik et al. 1995; Wagner et al. 1995; Davis
1996). This is also supported by familial clustering, as
illustrated by an estimated recurrence risk in siblings (lS)
of 15 (Risch 1987).
Monogenic or oligogenic forms of T1DM have been
described, and genetic studies in families affected with
it have allowed mapping of the corresponding genes to
chromosomes 10q25 and 2p12 (Verge et al. 1998; De-
le´pine et al. 2000). In the chromosome 2 region, disease-
causing mutations in the gene for eukaryotic transla-
tion-initiation factor–2 alpha kinase–3 gene (EIF2AK3)
have been identified in patients with Wolcott-Rallison
syndrome (neonatal insulin-dependent diabetes and ep-
iphyseal dysplasia) (Dele´pine et al. 2000).
The major histocompatibility complex (MHC) on
chromosome 6p21.3 is a major susceptibility locus (re-
ferred to as “IDDM1”) for the common multifactorial
from of T1DM (Nerup et al. 1974; Pociot 1996), es-
timated to account for 40%–50% of lS (Risch 1987).
The insulin-gene locus (IDDM2 [MIM 125852]) has
also been shown to contribute to disease susceptibility
(Bell et al. 1984; Julier et al. 1991). In addition, envi-
ronmental factors are also important in T1DM, as il-
lustrated by !100% concordance in MZ twins and by
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the increase in incidence, over time, in certain age
groups, particularly in the Scandinavian population (Di-
abetes Epidemiology Research International Group
1990; Tuomiletho et al. 1999; Dahlquist et al. 2000).
During the past decade, a large number of genetic
studies have been devoted to the search for additional
T1DM-susceptibility loci, either by linkage or by as-
sociation with candidate genes. The major findings of
these studies are summarized in table 1.
Both the relatively minor risk contribution of each of
the non-HLA loci and the possible genetic and/or en-
vironmental heterogeneity within and between studies
are likely to contribute to difficulties in replication of
some of these linkage results. Many studies have had
low power because of small sample sizes. In particular,
data stratification based on HLA genotype or other cri-
teria, which may be necessary for detection of the effects
of some of the susceptibility loci, further increases the
need for large sample sizes. In this context, it is probable
that identification of T1DM-susceptibility loci will re-
quire the combination of data from several large linkage
studies of multiple populations. Many of the previous
investigations have been performed in partially over-
lapping groups of patients (Davies et al. 1994; Hashi-
moto et al. 1994; Concannon et al. 1998; Mein et al.
1998). Consequently, the aim of this investigation was
to perform a genomewide search for T1DM-suscepti-
bility genes in an independent collection of patients,
consisting of 424 families (table 2) from Denmark, Nor-
way, and Sweden—a relatively homogeneous popula-
tion, in terms of its ethnic background and environ-
mental exposures.
Subjects and Methods
Patients and Families
DNA from families with at least two affected indi-
viduals other than parent-child pairs was collected in
Denmark, Norway, and Sweden (table 2). Individuals
were considered affected (1) if they had been diagnosed
with diabetes at age !15 years, required insulin treat-
ment at the time of onset, and had remained on insulin
treatment subsequently or (2) if diabetes with either ke-
toacidosis or requirement of insulin therapy from time
of onset had been diagnosed at age 115 years. The me-
dian age at onset was 13 years (range 0–71 years). It
previously had been shown that these criteria are con-
sistent with the diagnosis of T1DM (Mølbak et al.
1994). To exclude families with maturity-onset diabetes
of the young (MODY), the Danish families with diabetes
reported in three consecutive generations were screened
for MODY mutations. The Swedish families were iden-
tified through the two nationwide incidence registries:
the Swedish Childhood Registry (Dahlquist et al. 1982,
1985; Nystro¨m et al. 1990; Dahlquist and Mustonen
1994) and the Diabetes Incidence Study in Sweden (O¨st-
man et al. 1986; Blohme´ et al. 1992). The Danish fam-
ilies were identified through the Danish Study Group of
Diabetes in Childhood (Pociot et al. 1993), and the Dan-
ish IDDM Epidemiology and Genetics Group (Lorenzen
et al. 1998). The Norwegian families were recruited dur-
ing 1993–95, through advertisements, in the journal of
the Norwegian Diabetes Association, for families with
both (a) two sibs with T1DM and (b) parents without
the disease, and the recruitment was followed by phone
calls to include all family members. In most cases, blood
samples were obtained, by mail, from local physicians.
The diabetic siblings were asked to complete a form to
confirm T1DM; in cases in which these sibs were un-
certain of their T1DM status, their physicians were con-
tacted. During 1996–97, recruitment was extended by
letters to diabetes nurses ( ) at all pediatric andnp 480
internal medicine departments in Norway. In all, 408
multiplex families from Scandinavia, comprising 464 af-
fected full-sib pairs, were studied (table 2); when avail-
able, nonaffected siblings (216 nonaffected sib pairs)
were also included in the scan.
Complementary Families: French and U.S. Families
The French- and U.S.-family panels are identical to
those described elsewhere (Dele´pine et al. 1997). In all,
126 families with 158 affected sib pairs were available
from France, and 255 families with 310 affected sib pairs
were available from the United States. The latter were
obtained principally from the HBDI family collection.
DNA Extraction
DNA was extracted by standard procedures, by either
phenol/chloroform extraction or a salting-out method
(Miller et al. 1988).
Microsatellite Genotyping
The genomewide linkage study was undertaken by use
of the Medical Research Council (MRC) microsatellite
panel (Reed et al. 1997). Markers that did not pass our
quality-control procedures (see below) were replaced by
new markers selected from the Ge´ne´thon map. Addi-
tional markers were added both to regions that are
sparsely covered by the MRC panel and in three regions
of specific interest: HLA, on 6p21; IDDM15 (MIM
601666), on 6q21; and the EIF2AK3 locus, on 2p12.
Microsatellite markers were characterized by PCR
amplification with fluorescence-labeled primers on PTC-
225 thermocyclers (MJ Research). PCR was performed
in a final volume of 15 ml (Buffer 1# [ Perkin-Elmer],
0.2 mM dNTP, 1.5–3.0 mM MgCl2, 0.4 U Taq Gold,
0.2 mM of each primer, and 5–15 ng DNA). The samples
were amplified for 35 cycles, each consisting of 30 s at
94 C, 30 s at the primer-specific annealing temperature
Table 1
Summary of Previous Linkage Results and Exclusion Data from Present Study
LOCUS OR REGION CHROMOSOME MARKER(S)
DATA FROM
PRESENT STUDY LOD SCORES(S) FROM PREVIOUS STUDIES (REFERENCE[S])
IBDa
(%)
LOD
Scoreb
lS
Excluded Significance
Replication
Independent Overlapping
1 D1S1644-AGT 50.0 0 1.5 2.0 (Concannon et al. 1998) … …
IDDM7–IDDM12 2 HOXD8-D2S72-CTLA4 53.4 .79 2 3.6 (Owerbach and Gabbay
1995)
… 1.0 (Cordell et al. 1995; Luo et al. 1995; Concan-
non et al. 1998; Mein et al. 1998)
IDDM13 2 D2S137-D2S301 51.0 .04 1.5 2.0 (Morahan et al. 1996) … 1.0 (Concannon et al. 1998)
IDDM9 3 D3S1279 53.0 .53 2 2.0, female sib pairs (Paterson
and Petronis 1999)
… 1.0 (Cucca et al. 1998; Mein et al. 1998)
IDDM15 6 D6S283 (see table 4) … 3.6 (Dele´pine et al. 1997) … 2.0, not corrected for MHC (Concannon et al. 1998)
IDDM5 6 D6S476-D6S473 50.0 0 1.5 3.6 (Luo et al. 1996) 2.0 (Davies et al. 1994; Cucca et al.
1998), 1.0 (Mein et al. 1998)
1.0 (Davies et al. 1996; Concannon et al. 1998)
IDDM8 6 D6S446-D6S281 51.5 .12 1.5 3.6 (Luo et al. 1995) … 2.0 (Luo et al. 1995; Davies et al. 1996), 1.0
(Dele´pine et al. 1997; Concannon et al. 1998;
Cucca et al. 1998; Mein et al. 1998)
IDDM10 10 D10S191-D10S220 53.4 .47 2.0 3.6 (Mein et al. 1998) 2.0 (Hashimoto et al. 1994) 1.0 (Cucca et al. 1998)
IDDM17 10 D10S1750-D10S1773 52.0 .18 2.0 3.6 (Verge et al. 1998) 1.0 (Concannon et al. 1998)
IDDM2 11 INS 51.3 .07 1.5 2.0 (Mein et al. 1998) … 2.0, male sib pairs (Paterson and Petronis 1999)
IDDM4 11 D11S1296-FGF3 53.1 .49 2.0 3.6 (Luo et al. 1996) … 2.0 (Davies et al. 1994; Hashimoto et al. 1994)
14 D14S70-D14S276 50.0 0 1.5 2.0 (Mein et al. 1998) … …
IDDM11 14 D14S67 50.0 0 1.5 3.6 (Field et al. 1996) … …
16 D16S515-D16S520 52.3 .38 1.5 2.0 (Mein et al. 1998) … …
a Maximum value observed within the given interval; values !50% are shown as 50%.
b Maximum value observed within the given interval.
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Table 2
Families of Patients Included in Genomewide Linkage Analysis
Category Danish Norwegian Swedish Total
Sib pairs:
Affected 175 89 200 464
Unaffected 135 23 53 211
Discordant 287 127 277 691
Half-sib pairs:
Affected 0 1 13 14
Unaffected 0 0 4 4
Discordant 0 3 20 23
Affected father-child pairs 41 3 20 64
Affected mother-child pairs 12 4 8 24
Avuncular pairs 0 8 1 9
First-cousin pairs 0 0 2 2
Families:
Multiplex families 147 77 184 408
Simplexa 5 2 9 16
a These families were in the TDT analysis.
(45C–61C), and 30 s at 72C. Initial denaturation was
performed at 94C for 10 min, and a final elongation
step was performed at 72C for 1 min. PCR products
from 10–21 different primer pairs were pooled prior to
separation on either an ABI373 or an ABI377 (Applied
Biosystems), with either 12-cm or 36-cm well-to-read,
denaturing 6% polyacrylamide gels, followed by anal-
ysis using either version 1.2 or version 3.1 of GENE-
SCAN (Applied Biosystems). Single-strand size markers
GS-350 or GS-500 (Applied Biosystems) were used. The
allele assignments were made by version 2.0 of GENO-
TYPER (Applied Biosystems). Each gel contained an in-
ternal DNA control (individual 2 in CEPH family 1347;
Coriell Institute), which was used for calibration of the
allele sizes. In all, 324 markers were genotyped and in-
cluded in the scan before quality control was performed.
Family structures were reassessed and corrected on the
basis of the genomewide-scan data, by the SIBERROR
program, with markers separated by 130 cM (Ehm and
Wagner 1998). In particular, half-sibs and MZ twins
were identified, and one member in each MZ pair was
excluded from further analysis.
The following quality-control tests were routinely per-
formed for each marker (and genotypes were rechar-
acterized or removed as necessary): heterogeneity, in al-
lele frequencies, between gels (possibly due to differences
in allele sizing); Mendelian consistency, by the PED-
CHECK program (O’Connell and Weeks 1998); and ex-
cess of homozygosity (generally reflecting either missed
amplification of some alleles or, in heterozygotes, pref-
erential amplification of one allele). The observed num-
ber of homozygotes was compared with the number ex-
pected on the basis of the observed allele frequencies,
by a x2 test. A cutoff of was used. Special careP ! .001
was also given to ensure consistency in allele sizing
across all the families. These tests led to the exclusion
of six microsatellite markers, which displayed excess of
homozygosity that could not be corrected by reinter-
pretation of the gel data. Finally, we obtained consistent
and corrected genotypes for a total of 318 microsatellite
markers, which were used for analysis. The average suc-
cess rate for genotypes after the quality-control tests
were performed was 84.9%. The average heterozygosity
of the markers was .79 (range .56–.91).
HLA and INS Genotyping
The HLA-DRB1 (MIM 142857) genotype was de-
termined by allele-specific PCR for the DR3 and DR4
alleles (Olerup and Zetterquist 1992, 1993). To deter-
mine the susceptibility status at the INS (IDDM2) locus,
the INS polymorphism INS-23/HphI was genotyped
(Lucassen et al. 1993).
Genetic Map
The genetic map was assessed by both the CRIMAP
program and the ASPEX program (see the The ASPEX
Package: Affected Sib Pair Exclusion Mapping web site)
(Lander and Green 1987; Hauser et al. 1996), which gave
results that, in terms of marker order and distances, were
similar to those for the publicly available linkage maps
(e.g., that of the Center for Medical Genetics, Marshfield
Medical Research Foundation). To avoid possible distor-
tions of the map in families with diabetes due to adjacent
susceptibility loci, we used the Marshfield map distances
in the multilocus linkage analyses, with complementary
estimates from other publicly available linkage maps, ex-
trapolations from physical maps, and estimates from the
present T1DM-Scandinavian map, where necessary. The
average spacing between the 318 markers was 11.3 cM.
In all, 23 intermarker distances were 120 cM.
Linkage Analysis
Linkage was assessed by nonparametric linkage meth-
ods. First, the data were scanned by programs including
only nuclear families. Single-locus linkage analysis was
performed by the ANALYZE package. Multilocus linkage
analysis and exclusion mapping were performed by the
SIBIBD program from ASPEX (see the The ASPEX Pack-
age: Affected Sib Pair Exclusion Mapping web site) (pro-
vided by D. Hinds and N. Risch), under a multiplicative
model, as described elsewhere (Risch et al. 1999). Allele
frequencies in all family members were estimated by the
DOWNFREQ program. Additional single-locus and mul-
tilocus linkage analyses were performed by ALLEGRO
(Gudbjartsson et al. 2000), with similar results. For chro-
mosome X, MAPMAKER/SIBS (Kruglyak and Lander
1995) was also used for linkage calculations, as suggested
by Nyholt (2000), resulting in similar results. Loci reach-
ing a LOD score 2.0 in either the single-locus analysis
or the multilocus analysis were further investigated by
single-locus and multilocus linkage analyses by ALLE-
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GRO, which allowed the inclusion of all affected family
members (Gudbjartsson et al. 2000). A linear model with
equal weighting of affected relative pairs was used. No
correction was made for number of affected individu-
als in each family. Locus-specific lS was estimated as de-
scribed by Risch (1987).
Transmission/Disequilibrium Test (TDT) Analysis
TDT analysis was performed by the ANALYZE pro-
gram, with all affected siblings in each family (Terwil-
liger 1995).
Linkage Analysis for IDDM15
For IDDM15 on chromosome 6q, analysis was per-
formed, as described elsewhere (Dele´pine et al. 1997),
to correct for linkage to the HLA region. The analysis
was restricted to families in which the parental origin
of HLA and IDDM15 haplotypes could be determined.
HLA haplotypes were determined on the basis of HLA-
DRB1 and the nearby microsatellite markers D6S276,
D6S273, and TNFA. Marker D6S283 was chosen as the
marker locus for the IDDM15 locus (Dele´pine et al.
1997).
Stratification Based on Population of Origin, HLA, and
INS
Secondary statistical analyses were performed, with the
data subdivided by either population of origin, HLA type,
or INS genotype. For stratification based on HLA type,
families were divided into four independent groups: (1)
DR3/4, comprising families in which all the affected sib-
lings were HLA DR3/4 (132 families and 146 affected sib
pairs); (2) DR4, comprising families in which all affected
siblings carried HLA-DR4, excluding families in category
1 (164 families and 206 affected sib pairs); (3) DR3, com-
prising families in which all affected siblings carried HLA-
DR3, excluding those in category 1 (61 families and 69
affected sib pairs); and (4) other, comprising families in
which all affected siblings are neither DR3 nor DR4 (36
families and 53 affected sib pairs).
For stratification based on INS, positive susceptibility
(“”) was defined in terms of homozygosity (/) and
nonsusceptibility (“”) was defined in terms of other gen-
otypes (/ and /), where “” denotes the T1DM-
associated allele at the INS-23/HphI site, which is in
strong linkage disequilibrium with the small-size class at
the INS-5′VNTR polymorphism (Julier et al. 1994). Fam-
ilies were subdivided into three independent groups: (1)
INS, comprising families in which all affected sibs car-
ried the / genotype (239 families and 279 affected sib
pairs); (2) INS, comprising families in which all affected
siblings carried the / genotype (56 families and 60
affected sib pairs); and (3) INS/INS, comprising fam-
ilies in which affected siblings were discordant, or /
(98 families and 135 affected sib pairs). Results from the
secondary statistical analyses are reported only when the
results of tests for differences in linkage are significant at
(heterogeneity test).P ! .05
Results
Primary Linkage Analysis
Genotypes for 318 marker loci were obtained in 408
multiplex families (464 affected sib pairs). Multilocus-
LOD-score curves, plotted for the entire genome, to-
gether with the exclusion data (for effects of ),l  1.5S
are shown in figure 1. In addition to HLA, 14 regions
were detected with a LOD score of 1.0 in multilocus
analysis, 8 of which also were detected at this signifi-
cance level in single-locus analyses (table 3).
In multilocus analysis, a LOD score of 4.8 was ob-
served in the IDDM15 region (markers D6S300–
D6S283), corresponding to a secondary peak in the
broad HLA-linked region. LOD scores 12 were also ob-
served on chromosome 2, at D2S113 near EIF2AK3
(LOD score 2.1), on chromosome 5, near marker
D5S407 (LOD score 2.2), and on chromosome 16p, in
a wide region from D16S407 to D16S287 (LOD score
2.8). LOD scores of 1.0 in single- or multilocus analyses
were also observed on chromosomes 4, 9, 10, 12, 13
(two regions), 19 (two regions), 21, and X.
Susceptibility loci with were excluded froml p 1.5S
61% of the genome (LOD score !2.0). For ,l p 2.0S
89% of the genome was excluded. Apart from IDDM15,
none of the 17 previously reported non-HLA putative
susceptibility loci achieved a LOD score 10.8. Effects of
could be excluded at eight of the loci, effectsl  1.5S
of at the other five (table 1). However, linkagel  2.0S
in the presence of association was confirmed at the
IDDM2 locus (INS) by TDT, with an excess of trans-
mission of INS from heterozygous parents to diabetic
children (261 vs. 164; ); there was no distor-6Pp 10
tion in the transmission of INS alleles to nonaffected
children (84 vs. 89).
The IDDM15 region on chromosome 6q is linked to
HLA, with an estimated recombination rate (v) of .32
in male meioses and .47 in female meioses (Dele´pine et
al. 1997). Therefore, statistical analysis was performed
to evaluate the significance of cosegregation of IDDM15
with the disease, with the contribution from HLA being
taken into account. This yielded suggestive evidence of
linkage in the Scandinavian families, with atPp .002
marker D6S283, the marker that, in a previous analysis
(Dele´pine et al. 1997), had shown the strongest evidence
of linkage (table 4). We then combined the data from
the Scandinavian families with data from the French and
U.S. multiplex families. There was no evidence, at this
locus, of heterogeneity between the Scandinavian fam-
ilies and the French and U.S. families. Taking into ac-
Figure 1 Multipoint linkage analysis using ASPEX multipoint linkage analysis (solid line) and exclusion mapping (dashed line) using
ASPEX in all affected sib pairs. Genetic distances (in Kosambi Morgans) are given along the X-axis.
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Table 3
Regions with LOD Score 1.0: All Families
CHROMOSOME CLOSEST MARKER(S)a
RESULTS OF SINGLE-LOCUS
LINKAGE ANALYSISb
RESULTS OF MULTILOCUS
LINKAGE ANALYSISc
LOD
Score P
IBD
(%)
LOD
Score P
IBD
(%)
2 D2S113 2.10 49# 10 55.8 1.82 .002 55.6
4 D4S403 1.30 .007 55.1 1.84 .002 57.4
5 D5S407 1.93 .001 55.8 2.16 48# 10 56.1
6 TNFA (HLA region) 36.97 393# 10 75.9 42.62 457# 10 74.2
6 D6S300d 4.27 65# 10 58.8 4.85 61# 10 59.6
9 D9S118-D9S158 .63 .044 53.4 1.02 .015 55.6
10 D10S583 .90 .021 54.5 1.49 .004 55.2
12 D12S99 1.69 .003 55.1 1.97 .001 55.4
13 D13S218 .91 .02 55.1 1.32 .007 55.2
13 D13S285 1.14 .011 54.5 1.02 .015 54.6
16 D16S405-D16S287 2.36 45# 10 57.2 2.80 42# 10 56.7
19 D19S247-D19S901 .84 .024 53.4 1.26 .008 55.3
19 D19S217-D19S180 .87 .022 54.5 1.18 .01 56.0
21 D21S65-D21S167 .95 .018 53.9 1.23 .009 54.2
X MAOB 1.07 .013 56.5 1.00 .016 56.2
a Markers were considered to reflect the same susceptibility region when they were !10 cM apart
and were covered by a continuous LOD-score peak.
b Calculated by ANALYZE programs.
c Calculated by ASPEX programs.
d Linkage around D6S300 is within the HLA-linked regions but produces a separate peak in the
linkage curve. The LOD-score and P values for D6S300 are not corrected for linkage to HLA.
count the 95% confidence interval for the estimate of
the distance between HLA and D6S283, an estimate ob-
tained from data on the 59 large reference families from
the Centre d’E´tude du Polymorphisme Humain (Dele´-
pine et al. 1997), we estimated that the P value asso-
ciated with this statistic in the combined family set
would be ( for the recom-5 8 73# 10 –5# 10 7# 10
bination rates given above).
Secondary Linkage Analyses
Multilocus linkage analysis was also undertaken with
the data subdivided according to HLA subtype, INS sus-
ceptibility status, or population of origin (see the “Strat-
ification Based on Population of Origin, HLA, and INS”
subsection of Subjects and Methods), in regions with a
LOD score 11 in the primary analysis. This allowed for
testing of either heterogeneity of particular genetic effects
due to interaction with specific HLA- or INS-risk hap-
lotypes or population-of-origin heterogeneity for T1DM.
Table 5 shows the results when the test of heteroge-
neity between categories (HLA, INS, or population of
origin) was significant at . A chromosome regionP ! .05
near D16S405 on chromosome 16p displayed weak but
significant evidence of heterogeneity in the stratification
based on HLA ( ), with increased evidence ofPp .012
linkage in the DR3/4 group (LOD score 3.6; 65% IBD)
(table 5). In addition, a region near marker D16S3113
on chromosome 16p demonstrates significant evidence
of heterogeneity in the stratification based on INS
( ), with increased evidence of linkage in thePp .0005
INS group (LOD score 3.4; 71% IBD) (table 5). Weak
evidence of heterogeneity in the stratification based on
population of origin was found in the extended chro-
mosome 16p region near marker D16S3131 (Pp
), with increased evidence of linkage in the Danish.037
population (LOD score 2.8; 61% IBD) (table 5). Inter-
estingly, the three peaks observed in the HLA-DR3/4,
INS, and Danish groups have distinct positions within
the extended chromosome 16p region and cover a 30-
cM region (fig. 2). In addition, the region on chromo-
some 2p near marker D2S113 showed increased evi-
dence of linkage in the DR3/4 group (LOD score 2.7;
65% IBD), although the test for heterogeneity in the
stratification based on HLA did not reach statistical sig-
nificance ( ; data not shown). Evidence of linkageP 1 .05
under stratification based on either HLA, INS, or pop-
ulation of origin was not increased in the chromosome
5q region compared with the complete data set (data
not shown). There was also some evidence of hetero-
geneity in linkage to HLA when the data were stratified
on the basis of INS ( ), with increased evidencePp .012
of linkage in the INS group (85% IBD) compared both
with the INS group (71% IBD) and with the inter-
mediate IBD value in the INS/INS group (76%) (ta-
ble 5).
Two additional markers, D4S412 and D13S153, lo-
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Table 4
Results of IDDM15 Linkage Analysis, Adjusted for HLA Linkage, for Marker D6S283
ORIGIN AND HLA SPLITa
NO. OF INDIVIDUALSb OVERALL STATISTIC
All Males Females Weighted x2
PIBD1 IBD0 IBD1 IBD0 IBD1 IBD0 Male Female All
Scandinavia:
HLA 1 217 148 122 63 95 85 7.52 1.93 8.56 .002
HLA 0 74 61 33 32 41 29
France:
HLA 1 84 43 48 17 36 26 4.29 1.61 5.45 .01
HLA 0 13 17 5 10 8 7
United States:
HLA 1 205 130 105 64 100 66 1.32 10.10 9.39 .001
HLA 0 62 57 24 33 38 24
All:
HLA 1 506 321 275 144 231 177 11.65 11.62 23.27 77# 10
HLA 0 149 135 62 75 87 60
a HLA 1 p sharing of one HLA allele IBD; HLA 0 p sharing of no HLA allele IBD.
b IBD1 p inheritance of the same allele; IBD0 p inheritance of a different allele.
cated near markers detected with a LOD score 11.0 in
the complete data set (21 cM from D4S403 and 12.5
cM from D13S153) showed evidence of heterogeneity
when stratified on the basis of either HLA (Pp .031
and , respectively). The LOD was 2.6 in thePp .018
other-DR group, for D4S412, and was 3.2 in the DR4
group, for D13S153.
Linkage Analysis Using All Family Members
To include all affected individuals, linkage was cal-
culated, by the ALLEGRO program, for regions reach-
ing a LOD score of 2 in the primary linkage analysis.
These data are displayed in figure 2. On chromosome
2, the LOD score was 2.6 among patients who also
carried DR3/4. On chromosome 5, the LOD score was
2.2 in the complete data set, whereas it was 3.7 on chro-
mosome 16 among patients who also carried DR3/4 and
was 3.5 in the INS group (these peaks were 29 cM
apart).
Discussion
In the present genomewide linkage analysis in a large
collection of Scandinavian families, we confirmed link-
age to the disease-susceptibility loci IDDM1 (HLA re-
gion), IDDM2 (INS), and IDDM15. We also found sug-
gestive evidence of linkage (LOD score 12) in three
additional regions, on chromosomes 2p, 5p11-q13, and
16p. In the first and third of these three regions, the
evidence of linkage was increased in secondary analyses
when the data were stratified on the basis of either HLA
or INS. HLA was confirmed as a major susceptibility
locus for T1DM (multilocus LOD score 42.6), with an
observed locus-specific lS of ∼3.6. TDT analysis per-
formed with an INS variant associated with T1DM sus-
ceptibility provided confirmation of linkage to IDDM2
( ). The IDDM1 and IDDM2 loci showed mar-6Pp 10
ginally significant evidence of interaction ( ).Pp .012
Linkage to the INS region was not significant, as ex-
pected, because of the limited power of this approach,
given the low lS attributed to the locus because of the
high carrier frequency of the susceptibility allele in the
population (Julier et al. 1991; Spielman et al. 1993).
The pattern of linkage on 6q was similar to that ob-
served in French and U.S. families (Dele´pine et al. 1997),
with the LOD-score curve’s maxima occurring at
IDDM1 (HLA) and IDDM15 and being separated by
130 cM. After adjusting for linkage to IDDM1, we ob-
tained in the test for linkage to IDDM15 inPp .002
the Scandinavian families. However, 147 of the Danish
families were included in both the present study and the
original report of linkage to IDDM15 (Dele´pine et al.
1997). When the new data were combined with those
previously published on Danish, French, and U.S. fam-
ilies, the significance of the HLA-adjusted test statistic
was . Linkage at this locus has also been7Pp 7# 10
reported, in combined U.S. and U.K. families, by Con-
cannon et al. (1998), although the U.S. families in the
latter study overlap partially with both those in the re-
port by Dele´pine et al. (1997) and those in the present
study. Thus, the combined evidence in favor of IDDM15
is the most compelling that has been reported thus far
for any of the putative T1DM-susceptibility loci, except
for IDDM1 and IDDM2.
We selected additional markers on chromosome
2p12, to cover the region of EIF2AK3, which is mutat-
ed in patients with Wolcott-Rallison syndrome (Dele´-
pine et al. 2000). Although this syndrome is not known
to involve an autoimmune process, patients develop per-
manent insulin-dependent diabetes shortly after birth,
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Table 5
Analysis of Heterogeneity in IBD Sharing and Stratification
STRATIFICATION TYPE
AND CLOSEST MARKER
IBD
(%)
Pa HLA GROUPb
LOD
SCOREbDR3/4 DR4 DR3 Other
HLA:
D16S405 64.4 52.5 52.6 53.7 .012 DR3/4 3.60
INS INS/INS INS INS
INS:
INSD6S276 (HLA) 70.9 76.4 84.4 .012 INS
INSD16S3113 50.0 59.1 70.9 .0005 INS 3.42
Danish Swedish Norwegian POPULATION
Population of origin:
D16S3131 60.8 51.3 50.8 .037 Danish 2.80
a For test of heterogeneity in IBD sharing between groups listed.
b In the most linked group from the multilocus analysis.
which leads to the proposition that this gene is a can-
didate for T1DM (Dele´pine et al. 2000). The evidence
of linkage at this locus was increased in the HLA DR3/
4 sib pairs (multilocus LOD score 2.6), compared with
that observed in the complete data set. This suggests that
EIF2AK3—or another gene located in this region—may
contribute to T1DM susceptibility. The EIF2AK3 region
is distinct from the previously reported putative suscep-
tibility loci—IDDM7 (MIM 600321), IDDM12 (MIM
601388), and IDDM13 (MIM 601318)—on chromo-
some 2q (Cordell et al. 1995; Luo et al. 1995; Ower-
bach and Gabbay 1995; Concannon et al. 1998; Mein
et al. 1998). Significant linkage to the IDDM7–IDDM12
region has been reported, with replication, in a partly
independent data set (table 1). Suggestive linkage to
IDDM13 has been reported (table 1). CTLA4, which
maps to the IDDM12 region, has been shown to be as-
sociated with T1DM (Nistico` et al. 1996; Marron et al.
1997; Larsen et al. 1999). Since we have excluded linkage
to IDDM7–IDDM12 for , we cannot exclude thel  2S
possibility that this region contains a gene with a rela-
tively small effect on the risk for development of T1DM.
The IDDM13 region was excluded at , sug-l  1.5S
gesting that this region either does not contain a suscep-
tibility gene in this population or contains one with a
very small effect on the risk for T1DM.
The region of linkage on chromosome 16p extends
over ∼50 cM between D16S405 and D16S207 (fig. 2).
Furthermore, increased evidence of linkage with het-
erogeneity was obtained in groups defined on the basis
of HLA, INS, and population of origin, with peaks in
the three groups extending over a 30-cM region. The
1-LOD support interval for the HLA-DR3/4 and INS
groups did not overlap (being located at 0–22 and
26–45 cM respectively; see fig. 2). In addition, single-
point data in the INS group reached its maximum for
D16S3113 and D16S3131 (LOD score 2.9 and 3.0, re-
spectively) whereas in the DR3/4 group the LOD score
for these markers was 0.2 and 0.1, respectively. These
observations suggest that this extended region contains
more than one T1DM-susceptibility locus. However,
simulation studies have shown that linkage analysis of
multifactorial diseases may lead to linkage peaks some
distance from the causative genetic effect (Roberts et al.
1999). The region partly overlaps that reported at
D16S420–D16S261 (Mein et al. 1998), for which a
LOD score of 1.2 was found in the UK263-family sub-
set. In the U.K. study, the LOD score was also greater
in HLA-DR3/4 sib pairs (LOD score 2.2). However, this
region is distinct from a second region, on 16q22-q24,
that has been reported to be linked to T1DM in U.K.
families (Mein et al. 1998).
Suggestive evidence of linkage on chromosome 5p11-
q13 also was found. This region had not previously been
linked to T1DM; however, in two independent studies
of multiple sclerosis, evidence of linkage had been found
in this region. In one study, a LOD 13 was reached with
a dominant model of inheritance (Kuokkanen et al.
1996; Sawcer et al. 1996; Oturai et al. 1999). This
region is different both from the recently reported
IDDM18 (MIM 605598) locus (IL12B) at 5q31.1-
q33.1 (Morahan et al. 2001) and from other chromo-
some 5 T1DM loci reported in U.K. families (Mein et
al. 1998).
Eleven other chromosome regions were identified that
have nominal evidence of linkage ( ; ta-.05 1 P 1 .00074
ble 3). Although some of these overlap putative regions
with T1DM-susceptibility loci from the literature, the
data presently available are not sufficient to determine
which, if any, of these regions contain disease-suscep-
tibility loci. Effects of could be excluded atl  1.5S
previously reported T1DM loci on chromosome 1, 6,
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Figure 2 Multipoint linkage analysis using ALLEGRO, in HLA
DR3/4 families (thinner black hashed line), non-DR3/4 families (thin-
ner black solid line), INS families (gray hashed line), INS families
(solid gray line), and all families (thicker black solid line). A linear
model and equal weighting of all families were used.
11, 14, 16, and 18 (table 1 and fig. 1), showing that
these loci per se do not play a detectable role in T1DM
susceptibility in the Scandinavian population.
We have observed significant heterogeneity in IBD
sharing, for the chromosome 16 region, when sib pairs
were grouped on the basis of shared HLA alleles (table
5). Similar results also were observed, for both the chro-
mosome 16 region and the HLA region, when sib pairs
were grouped on the basis of shared INS genotype (table
5). This suggests that there is both an interaction be-
tween the chromosome 16 region and both the HLA
and INS and, similarly, an interaction between the INS
and HLA loci. The LOD-score differences between dif-
ferent HLA and INS groups, presented in figure 2, are
exploratory in nature and do not prove an interaction,
for example, between the chromosome 2 region and the
HLA region.
The results of this study demonstrate highly signifi-
cant evidence of linkage to IDDM15 at 6q, when data
from the present study are combined with those from
previous investigations. Evidence of interaction between
susceptibility loci for T1DM has been obtained in a
number of studies (Davies et al. 1994; Cordell et al.
1995; Mein et al. 1998). This concept is supported in
the present study, in particular by the results obtained,
after stratification based on either HLA or INS, on link-
age to chromosome 16p (table 5). Gene-gene interaction
is clearly an important feature of genetic predisposition,
and studies addressing this are very much in demand
to explain the molecular basis of disease and to develop
new intervention modalities. Extensive investigations of
populations, such as the Scandinavian families studied
here, and the combination of data from multiple sources
are required to obtain the requisite power to detect in-
teracting loci with relatively small effects on familial
recurrence risk of the disease.
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